Atossa Therapeutics announces support of final rule from FDA
PremiumThe FlyAtossa Therapeutics announces support of final rule from FDA
2M ago
Atos Shares Drop on Reduced Financial Targets
Premium
Market News
Atos Shares Drop on Reduced Financial Targets
2M ago
Atossa Therapeutics granted U.S. patent for endoxifen
Premium
The Fly
Atossa Therapeutics granted U.S. patent for endoxifen
2M ago
Atossa Therapeutics reports Q2 EPS (5c), consensus (6c)
PremiumThe FlyAtossa Therapeutics reports Q2 EPS (5c), consensus (6c)
3M ago
Atossa Therapeutics completes enrollment of 80mg PK run-in cohort
Premium
The Fly
Atossa Therapeutics completes enrollment of 80mg PK run-in cohort
4M ago
Atossa Therapeutics appoints Heather Rees as CFO
Premium
The Fly
Atossa Therapeutics appoints Heather Rees as CFO
4M ago
Atossa Therapeutics files $100M mixed securities shelf
PremiumThe FlyAtossa Therapeutics files $100M mixed securities shelf
6M ago
Atossa Therapeutics price target raised to $6 from $4 at H.C. Wainwright
Premium
The Fly
Atossa Therapeutics price target raised to $6 from $4 at H.C. Wainwright
6M ago
Atossa Therapeutics reports Q1 EPS (5c), consensus (7c)
Premium
The Fly
Atossa Therapeutics reports Q1 EPS (5c), consensus (7c)
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100